Table 2.
The univariate and multivariate Cox analysis for overall survival in cervical cancer
| Characteristics | Univariate Cox analysis | Multivariate Cox analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | P | HR | 95%CI | P | |
|
Age (≥ 50 vs. <50) |
1.014 | 0.408–2.520 | 0.976 | |||
|
Type (Adenocarcinoma vs. SCC) |
1.736 | 0.682–4.415 | 0.247 | |||
|
Differentiation (High vs. Medium/Low) |
2.891 | 0.384–21.790 | 0.303 | |||
|
Stage (≥ IB3 vs. < IB3) |
7.631 | 1.758–33.134 | 0.007 | 4.798 | 1.053–21.864 | 0.043 |
|
LNM (Positive vs. Negative) |
3.597 | 1.292–10.017 | 0.014 | 1.339 | 0.455–3.938 | 0.596 |
|
LVSI (Positive vs. Negative) |
2.416 | 0.971–6.012 | 0.058 | |||
|
STEAP3 (High vs. Low) |
7.116 | 1.996–25.375 | 0.002 | 4.435 | 1.194–16.472 | 0.026 |
SCC, squamous cell carcinoma; LNM, lymph node metastasis; LVSI, lymphovascular space invasion